{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:51:29Z","timestamp":1793397089542,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00062"],"award-info":[{"award-number":["75N93019C00062"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI073755"],"award-info":[{"award-number":["R01 AI073755"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI125202"],"award-info":[{"award-number":["R01 AI125202"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI145012"],"award-info":[{"award-number":["R21 AI145012"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 AI007163"],"award-info":[{"award-number":["T32 AI007163"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI115577"],"award-info":[{"award-number":["U01 AI115577"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host &amp; Microbe"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.chom.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T19:24:36Z","timestamp":1633375476000},"page":"1634-1648.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity"],"prefix":"10.1016","volume":"29","author":[{"given":"Rita E.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma S.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"VanBlargan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandni","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerito","family":"Amaro-Carambot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jane","family":"Cardosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Sariol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esper G.","family":"Kallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafick-Pierre","family":"S\u00e9kaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Vasilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daved H.","family":"Fremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore C.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2021.09.006_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2008.08.021","article-title":"Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation","volume":"381","author":"Ansarah-Sobrinho","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.chom.2021.09.006_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.chom.2021.09.006_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1107\/S0907444909007835","article-title":"ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments","volume":"65","author":"Bond","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.chom.2021.09.006_bib4","doi-asserted-by":"crossref","first-page":"e1760","DOI":"10.1371\/journal.pntd.0001760","article-title":"Refining the global spatial limits of dengue virus transmission by evidence-based consensus","volume":"6","author":"Brady","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib5","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1128\/JVI.01190-10","article-title":"Genotype-specific neutralization and protection by antibodies against dengue virus type 3","volume":"84","author":"Brien","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib6","first-page":"15D.3.1","article-title":"Propagation, quantification, detection, and storage of West Nile virus","volume":"31","author":"Brien","year":"2013","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.chom.2021.09.006_bib7","doi-asserted-by":"crossref","first-page":"e0006209","DOI":"10.1371\/journal.pntd.0006209","article-title":"Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein","volume":"12","author":"Budigi","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera","volume":"70","author":"Calisher","year":"1989","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib9","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1371\/journal.pntd.0000423","article-title":"Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic fever","volume":"3","author":"Cardosa","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib10","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3390\/v3091562","article-title":"Dengue--quo tu et quo vadis?","volume":"3","author":"Chen","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.chom.2021.09.006_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2020.09.001","article-title":"Dengue mouse models for evaluating pathogenesis and countermeasures","volume":"43","author":"Chen","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/vaccines8010039","article-title":"Humanized mice in dengue research: a comparison with other mouse models","volume":"8","author":"Coronel-Ruiz","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.chom.2021.09.006_bib13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.80.3.1290-1301.2006","article-title":"West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection","volume":"80","author":"Davis","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.chom.2021.09.006_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.chom.2021.09.006_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/vaccines8010063","article-title":"A review on dengue vaccine development","volume":"8","author":"Deng","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.chom.2021.09.006_bib17","series-title":"Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control","article-title":"WHO guidelines approved by the guidelines review committee","author":"WHO","year":"2009"},{"key":"10.1016\/j.chom.2021.09.006_bib18","doi-asserted-by":"crossref","first-page":"11726","DOI":"10.1128\/JVI.01140-14","article-title":"Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition","volume":"88","author":"Dowd","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3\u2032-untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2021.09.006_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4161\/hv.2.4.2944","article-title":"The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers","volume":"2","author":"Durbin","year":"2006","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.chom.2021.09.006_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/427780","article-title":"rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers","volume":"191","author":"Durbin","year":"2005","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2016.01.002","article-title":"The development of therapeutic antibodies against dengue virus","volume":"128","author":"Fibriansah","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.chom.2021.09.006_bib23","doi-asserted-by":"crossref","first-page":"e0004398","DOI":"10.1371\/journal.pntd.0004398","article-title":"Incomplete protection against dengue virus Type 2 Re-infection in Peru","volume":"10","author":"Forshey","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib24","doi-asserted-by":"crossref","first-page":"e1251","DOI":"10.1371\/journal.pntd.0001251","article-title":"First report of sylvatic DENV-2-associated dengue hemorrhagic fever in West Africa","volume":"5","author":"Franco","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib25","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1371\/journal.pntd.0000617","article-title":"Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006","volume":"4","author":"Fried","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib26","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.celrep.2018.10.006","article-title":"Genetic variation between dengue virus Type 4 strains impacts human antibody binding and neutralization","volume":"25","author":"Gallichotte","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.chom.2021.09.006_bib27","doi-asserted-by":"crossref","first-page":"e1006178","DOI":"10.1371\/journal.ppat.1006178","article-title":"A single mutation in the envelope protein modulates Flavivirus antigenicity, stability, and pathogenesis","volume":"13","author":"Goo","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chom.2021.09.006_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.chom.2018.04.003","article-title":"An immunocompetent mouse model of Zika virus infection","volume":"23","author":"Gorman","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2021.09.006_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4269\/ajtmh.1990.42.179","article-title":"Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study","volume":"42","author":"Guzm\u00e1n","year":"1990","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2021.09.006_bib30","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2021.09.006_bib31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.chom.2021.09.006_bib32","first-page":"311","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered","volume":"42","author":"Halstead","year":"1970","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.chom.2021.09.006_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/128.1.7","article-title":"Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection","volume":"128","author":"Halstead","year":"1973","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib34","first-page":"351","article-title":"Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and dengue-exposed individuals","volume":"215","author":"Henein","year":"2017","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1567-1348(03)00004-2","article-title":"The origin, emergence and evolutionary genetics of dengue virus","volume":"3","author":"Holmes","year":"2003","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.chom.2021.09.006_bib36","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib37","doi-asserted-by":"crossref","first-page":"E8378","DOI":"10.1073\/pnas.1714250115","article-title":"Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials","volume":"115","author":"Juraska","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2021.09.006_bib38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(20)30023-2","article-title":"Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial","volume":"20","author":"Kallas","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib39","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.aac5017","article-title":"Dengue viruses cluster antigenically but not as discrete serotypes","volume":"349","author":"Katzelnick","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.chom.2021.09.006_bib40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.chom.2021.09.006_bib41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virol.2008.08.008","article-title":"Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model","volume":"380","author":"Kyle","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.chom.2021.09.006_bib42","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1128\/JVI.01420-07","article-title":"Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody","volume":"81","author":"Lai","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jtbi.2001.2347","article-title":"The geometry of shape space: application to influenza","volume":"212","author":"Lapedes","year":"2001","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.chom.2021.09.006_bib44","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1128\/JVI.02340-13","article-title":"The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states","volume":"87","author":"Lee","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib45","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/340365","article-title":"Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections","volume":"185","author":"Libraty","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib46","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.3201\/eid2212.160813","article-title":"Highly divergent dengue virus Type 2 in traveler returning from Borneo to Australia","volume":"22","author":"Liu","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib47","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.ymthe.2017.06.020","article-title":"Dengue virus evades AAV-mediated neutralizing antibody prophylaxis in rhesus monkeys","volume":"25","author":"Magnani","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.chom.2021.09.006_bib48","doi-asserted-by":"crossref","first-page":"e54220","DOI":"10.1371\/journal.pone.0054220","article-title":"Tracking the evolution of dengue virus strains D2S10 and D2S20 by 454 pyrosequencing","volume":"8","author":"Makhluf","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.chom.2021.09.006_bib49","doi-asserted-by":"crossref","first-page":"108226","DOI":"10.1016\/j.celrep.2020.108226","article-title":"Antigenic variation of the dengue virus 2 genotypes impacts the neutralization activity of human antibodies in vaccinees","volume":"33","author":"Martinez","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.chom.2021.09.006_bib50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/00034983.1957.11685829","article-title":"Genetical aspects of the Aedes aegypti problem. I. Taxonom: and bionomics","volume":"51","author":"Mattingly","year":"1957","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.chom.2021.09.006_bib51","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","article-title":"The current and future global distribution and population at risk of dengue","volume":"4","author":"Messina","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.chom.2021.09.006_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tim.2013.12.011","article-title":"Global spread of dengue virus types: mapping the 70 year history","volume":"22","author":"Messina","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.chom.2021.09.006_bib53","doi-asserted-by":"crossref","first-page":"e27715","DOI":"10.4161\/jkst.27715","article-title":"STAT2 signaling and dengue virus infection","volume":"3","author":"Morrison","year":"2014","journal-title":"JAK-STAT"},{"key":"10.1016\/j.chom.2021.09.006_bib54","doi-asserted-by":"crossref","first-page":"e1003265","DOI":"10.1371\/journal.ppat.1003265","article-title":"Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling","volume":"9","author":"Morrison","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.chom.2021.09.006_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4939-0348-1_6","article-title":"Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection","volume":"1138","author":"Mukherjee","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.chom.2021.09.006_bib56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2016.06.022","article-title":"Enhancing dengue virus maturation using a stable furin over-expressing cell line","volume":"497","author":"Mukherjee","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.chom.2021.09.006_bib57","doi-asserted-by":"crossref","first-page":"e1000060","DOI":"10.1371\/journal.ppat.1000060","article-title":"Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization","volume":"4","author":"Nelson","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chom.2021.09.006_bib58","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.chom.2019.10.005","article-title":"Persistent dengue infection in an immunosuppressed patient reveals the roles of humoral and cellular immune responses in virus clearance","volume":"26","author":"Ng","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2021.09.006_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02041-16","article-title":"Mapping the human memory B cell and serum neutralizing antibody responses to dengue virus Serotype 4 infection and vaccination","volume":"91","author":"Nivarthi","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.342.6157.415","article-title":"Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts","volume":"342","author":"Normile","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.chom.2021.09.006_bib61","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib62","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.antiviral.2017.05.007","article-title":"Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates","volume":"144","author":"Ong","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.chom.2021.09.006_bib63","doi-asserted-by":"crossref","first-page":"e0005554","DOI":"10.1371\/journal.pntd.0005554","article-title":"Dissecting the human serum antibody response to secondary dengue virus infections","volume":"11","author":"Patel","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib64","series-title":"Fields Virology","article-title":"Flaviviruses","author":"Pierson","year":"2013"},{"key":"10.1016\/j.chom.2021.09.006_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.chom.2021.09.006_bib66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.meegid.2018.04.032","article-title":"Understanding dengue virus evolution to support epidemic surveillance and counter-measure development","volume":"62","author":"Pollett","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.chom.2021.09.006_bib67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S0022172400070923","article-title":"Immunological enhancement and the pathogenesis of dengue haemorrhagic fever","volume":"89","author":"Porterfield","year":"1982","journal-title":"J.\u00a0Hyg. (Lond)"},{"key":"10.1016\/j.chom.2021.09.006_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00546-17","article-title":"Complete genome sequence of a highly divergent dengue virus Type 2 strain, imported into Australia from Sabah, Malaysia","volume":"5","author":"Pyke","year":"2017","journal-title":"Genome Announc"},{"key":"10.1016\/j.chom.2021.09.006_bib69","doi-asserted-by":"crossref","first-page":"22356","DOI":"10.1038\/srep22356","article-title":"Highly divergent dengue virus type 1 genotype sets a new distance record","volume":"6","author":"Pyke","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2021.09.006_bib70","doi-asserted-by":"crossref","first-page":"e24196","DOI":"10.7554\/eLife.24196","article-title":"Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy","volume":"6","author":"Rabaa","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.chom.2021.09.006_bib71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.1812055115","article-title":"Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies","volume":"116","author":"Raut","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2021.09.006_bib72","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0042-6822(90)90102-W","article-title":"Molecular evolution and distribution of dengue viruses type 1 and 2 in nature","volume":"174","author":"Rico-Hesse","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.chom.2021.09.006_bib73","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/viro.1997.8504","article-title":"Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas","volume":"230","author":"Rico-Hesse","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.chom.2021.09.006_bib74","first-page":"225","article-title":"The dengue group of viruses and its family relationships","volume":"14","author":"Sabin","year":"1950","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.chom.2021.09.006_bib75","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2021.09.006_bib76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41541-017-0019-3","article-title":"Antibody therapies for the prevention and treatment of viral infections","volume":"2","author":"Salazar","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.chom.2021.09.006_bib77","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1016\/j.vaccine.2015.09.112","article-title":"Mouse\u00a0models of dengue virus infection for vaccine testing","volume":"33","author":"Sarathy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2021.09.006_bib78","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fimmu.2014.00452","article-title":"Utility, limitations, and future of non-human primates for dengue research and vaccine development","volume":"5","author":"Sariol","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chom.2021.09.006_bib79","series-title":"The PyMOL Molecular Graphics System, Version 2.0 Schr\u00f6dinger","author":"Schr\u00f6dinger","year":"2017"},{"key":"10.1016\/j.chom.2021.09.006_bib80","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri3916","article-title":"New insights into the immunopathology and control of dengue virus infection","volume":"15","author":"Screaton","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.chom.2021.09.006_bib81","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.chom.2021.09.006_bib82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.chom.2021.09.006_bib83","doi-asserted-by":"crossref","first-page":"e00813","DOI":"10.1128\/mBio.00873-13","article-title":"The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein","volume":"4","author":"Smith","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.chom.2021.09.006_bib84","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2021.09.006_bib85","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2144\/00286ir01","article-title":"The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences","volume":"28","author":"Stothard","year":"2000","journal-title":"BioTechniques"},{"key":"10.1016\/j.chom.2021.09.006_bib86","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1128\/JVI.01087-10","article-title":"Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2","volume":"84","author":"Sukupolvi-Petty","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib87","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1128\/JVI.01314-13","article-title":"Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection","volume":"87","author":"Sukupolvi-Petty","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib88","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.chom.2021.09.006_bib89","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(20)30556-0","article-title":"Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2\u201317 years: a randomised, placebo-controlled, phase 2 trial","volume":"395","author":"Tricou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2021.09.006_bib90","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/MMBR.00024-15","article-title":"Deconstructing the antiviral neutralizing-antibody response: implications for vaccine development and immunity","volume":"80","author":"VanBlargan","year":"2016","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.chom.2021.09.006_bib91","doi-asserted-by":"crossref","first-page":"e1003761","DOI":"10.1371\/journal.ppat.1003761","article-title":"The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein","volume":"9","author":"VanBlargan","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chom.2021.09.006_bib92","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrmicro2595","article-title":"Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health","volume":"9","author":"Vasilakis","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.chom.2021.09.006_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib94","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chom.2021.09.006_bib95","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jiw099","article-title":"Homotypic dengue virus reinfections in Nicaraguan children","volume":"214","author":"Waggoner","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2021.09.006_bib96","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/JVI.74.7.3227-3234.2000","article-title":"Evolutionary relationships of endemic\/epidemic and sylvatic dengue viruses","volume":"74","author":"Wang","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2021.09.006_bib98","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13071-017-2341-z","article-title":"Abundance and distribution of sylvatic dengue virus vectors in three different land cover types in Sarawak, Malaysian Borneo","volume":"10","author":"Young","year":"2017","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.chom.2021.09.006_bib99","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2014.00151","article-title":"Mouse models to study dengue virus immunology and pathogenesis","volume":"5","author":"Zellweger","year":"2014","journal-title":"Front. Immunol."}],"container-title":["Cell Host &amp; Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312821004224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312821004224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:28:38Z","timestamp":1761827318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312821004224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":98,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1931312821004224"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2021.09.006","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}